Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alicia Kaplan

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
CNS Spectrums|March 6, 2004
Comorbidity in compulsive hoarding: a case reportAlicia Kaplan, Eric Hollander
Psychiatric Services (Washington, D.C.)|July 29, 2003
A review of pharmacologic treatments for obsessive-compulsive disorderAlicia Kaplan, Eric Hollander
The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry|February 13, 2003
A double-blind, placebo-controlled trial of clonazepam in obsessive-compulsive disorderEric Hollander, Alicia Kaplan, Stephen M Stahl
Applied Psychophysiology and Biofeedback|April 29, 2020
Evaluating the Impact of Freespira on Panic Disorder Patients' Health Outcomes and Healthcare Costs within the Allegheny Health NetworkAlicia Kaplan, Anthony P Mannarino, P V Nickell
Environmental Geochemistry and Health|January 11, 2021
Metal distribution, bioavailability and isotope variations in polluted soils from Lower Swansea Valley, UKKathrin Schilling, Anirban Basu, Alicia Kaplan, et al.
International Journal of Psychiatry in Clinical Practice|August 29, 2013
An open-label trial of duloxetine in patients with irritable bowel syndrome and comorbid generalized anxiety disorderAlicia Kaplan, Michael D Franzen, P V Nickell, et al.
The Journal of Neuropsychiatry and Clinical Neurosciences|January 3, 2006
Neurological soft signs as predictors of treatment response to selective serotonin reuptake inhibitors in obsessive-compulsive disorderEric Hollander, Alicia Kaplan, James Schmeidler, et al.
CNS Spectrums|January 30, 2008
An open-label trial of venlafaxine in body dysmorphic disorderAndrea Allen, Sallie Jo Hadley, Alicia Kaplan, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
CNS Spectrums|March 6, 2004
Comorbidity in compulsive hoarding: a case reportAlicia Kaplan, Eric Hollander
Psychiatric Services (Washington, D.C.)|July 29, 2003
A review of pharmacologic treatments for obsessive-compulsive disorderAlicia Kaplan, Eric Hollander
The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry|February 13, 2003
A double-blind, placebo-controlled trial of clonazepam in obsessive-compulsive disorderEric Hollander, Alicia Kaplan, Stephen M Stahl
Applied Psychophysiology and Biofeedback|April 29, 2020
Evaluating the Impact of Freespira on Panic Disorder Patients' Health Outcomes and Healthcare Costs within the Allegheny Health NetworkAlicia Kaplan, Anthony P Mannarino, P V Nickell
Environmental Geochemistry and Health|January 11, 2021
Metal distribution, bioavailability and isotope variations in polluted soils from Lower Swansea Valley, UKKathrin Schilling, Anirban Basu, Alicia Kaplan, et al.
International Journal of Psychiatry in Clinical Practice|August 29, 2013
An open-label trial of duloxetine in patients with irritable bowel syndrome and comorbid generalized anxiety disorderAlicia Kaplan, Michael D Franzen, P V Nickell, et al.
The Journal of Neuropsychiatry and Clinical Neurosciences|January 3, 2006
Neurological soft signs as predictors of treatment response to selective serotonin reuptake inhibitors in obsessive-compulsive disorderEric Hollander, Alicia Kaplan, James Schmeidler, et al.
CNS Spectrums|January 30, 2008
An open-label trial of venlafaxine in body dysmorphic disorderAndrea Allen, Sallie Jo Hadley, Alicia Kaplan, et al.
Pageof 1